Source: Annual Congress 2006 - Recent advances in the treatment of COPD and acute lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ergen, S. Sarac, A. Saygili, Z. Arslan (Istanbul, Adiyaman, Turkey). Relation of low serum lipid levels with coronary atherosclerosi in COPD patients. Eur Respir J 2006; 28: Suppl. 50, 3843

Member's Comments

No comment yet.

Related content which might interest you: Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Elevated serum levels of oxidized low-density lipoprotein in COPD patients Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Gender differences in plasma biomarkers levels in patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 HDL serum levels are significantly lower in patients with COPD than in never-smokers Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Magnesium levels in erythrocytes and plasma in patients with exacerbated COPD Source: Eur Respir J 2001; 18: Suppl. 33, 429s Year: 2001 Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005